PMC:7696151 / 48613-48866 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1399","span":{"begin":42,"end":50},"obj":"Species"},{"id":"1407","span":{"begin":5,"end":8},"obj":"Chemical"},{"id":"1408","span":{"begin":111,"end":114},"obj":"Chemical"},{"id":"1409","span":{"begin":224,"end":227},"obj":"Chemical"},{"id":"1429","span":{"begin":22,"end":41},"obj":"Disease"}],"attributes":[{"id":"A1399","pred":"tao:has_database_id","subj":"1399","obj":"Tax:9606"},{"id":"A1407","pred":"tao:has_database_id","subj":"1407","obj":"MESH:D006886"},{"id":"A1408","pred":"tao:has_database_id","subj":"1408","obj":"MESH:D006886"},{"id":"A1409","pred":"tao:has_database_id","subj":"1409","obj":"MESH:D006886"},{"id":"A1429","pred":"tao:has_database_id","subj":"1429","obj":"MESH:D008180"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s of HCQ on quiescent lupus erythematosus patients, revealing that a reduction by up to 57% is associated with HCQ maintaining treatment (272 mg/day) [84]. A case-control study was carried out in order to define the role of HCQ in the survival of indivi"}